CGD Policy Blogs
The decision to allocate $650 billion of special drawing rights from the International Monetary Fund to the global economy is welcome. One way to use this extra ration of global liquidity will be to bolster the concessional lending pot the IMF has to help low-income countries—the Poverty Reduction and Growth Trust.
Early on in the COVID-19 pandemic, researchers grappled with an ethical and methodological dilemma: should they integrate measures of violence against women and children into remote data collection efforts—and if so, what logistical protocols were required to safeguard participants against harm? Despite decades of good practice guidelines, institutional ethical boards are often ill-equipped to advise or make determinations on violence data collection, and this is especially true for less traditional remote surveys. Thus, researchers may end up making decisions on what to ask—and what ethical protocol to put in place—based on their experience, knowledge of the study population (setting), and their comfort level with including sensitive questions.
India’s second COVID-19 wave has been explosive, reaching world record totals of over 300,000 daily officially reported cases. The true number is likely to be much higher, with a large number of cases missed as indicated by the delays in testing and rapidly rising positivity rates - currently one in every four people tested are positive for COVID-19 across India. Leading models estimate that there could be over 1 million cases per day. The health service has collapsed, with queues of ambulances parked outside full hospitals, oxygen and drug shortages in multiple states, and life-saving non-COVID services interrupted.
Rapid Priority Setting in Low- and Middle-Income Countries: The Potential of Adaptive Health Technology Assessments
Health budgets are limited and decision makers in all countries face very challenging decisions about which health interventions will be provided, and which will not. COVID has only added to this pressing priority setting problem. In this blog, we highlight key takeaways from our recent commentary in the BMJ Global Health, where we make the case for “adaptive health technology assessment,” or “aHTA.”
As the new US administration seeks to manage a large spike in migrants at the southern border, it has signaled plans to try to influence migrant decision-making in Central America through extensive public information campaigns.
Enough. We cannot continue business as usual. Until this crisis is over—and over everywhere—exiting the COVID-19 mass casualty event must be the singular focus of the international community.
2021 was to be the year in which the UK took leadership of global education. So it’s devastating that, instead of demonstrating its commitment to education during this moment in the spotlight, the UK government has chosen to cut education spending by more than 40 percent, compared with overall aid cuts of around 25 percent.
Among the many disparities and inequities that COVID-19 has shone a light upon, the chasm in health outcomes between rich and poor countries is being particularly sharply highlighted. While Israel, the US, the UK, and a handful of high- and upper-middle income countries are charging forward with their vaccination programmes, many of the poorest are left behind—sometimes to rapidly soaring infection rates, as in India. Universal health—that is, a basic level of health and nutrition achieved globally—seems a distant prospect.
COVID-19 and the economic crisis it unleashed have spurred unprecedented action from governments and international institutions. Multilateral development banks (MDBs) like the Asian Development Bank (ADB) swiftly committed resources to COVID-19 response and recovery efforts in 2020 and 2021, including a $20 billion countercyclical support facility and a $9 billion facility specifically for COVID-19 vaccine procurement and vaccination program implementation.